Segment Information (Tables)

6 Months Ended

Jun. 30, 2020

Segment Reporting [Abstract]

Financial Data By Reportable Segment

Financial data by reportable segment for the three and six months ended June 30, 2020 and 2019 is as follows:

	Commercial & Specialty Business		Government Business		IngenioRx		Other			Eliminations			Total
Three Months Ended June 30, 2020
Operating revenue - unaffiliated	$	8,789	$	17,242	$	2,544	$	603		$	—		$	29,178
Operating revenue - affiliated	—		—		2,725		849			(3,574		)	—
Operating gain	1,372		1,618		304		66			—			3,360
Three Months Ended June 30, 2019
Operating revenue - unaffiliated	$	9,417	$	15,538	$	145	$	77		$	—		$	25,177
Operating revenue - affiliated	—		—		103		469			(572		)	—
Operating gain (loss)	983		480		—		(30		)	—			1,433
Six Months Ended June 30, 2020
Operating revenue - unaffiliated	$	18,150	$	34,708	$	4,887	$	881		$	—		$	58,626
Operating revenue - affiliated	—		—		5,579		1,598			(7,177		)	—
Operating gain	2,792		2,029		653		80			—			5,554
Six Months Ended June 30, 2019
Operating revenue - unaffiliated	$	18,809	$	30,464	$	145	$	147		$	—		$	49,565
Operating revenue - affiliated	—		—		103		947			(1,050		)	—
Operating gain (loss)	2,581		854		—		(62		)	—			3,373

Major Product Revenue by Segment

The major product revenues for each of the reportable segments for the three and six months ended June 30, 2020 and 2019 are as follows:

	Three Months Ended   June 30						Six Months Ended   June 30
	2020			2019			2020			2019
Commercial & Specialty Business
Managed care products	$	7,132		$	7,646		$	14,700		$	15,264
Managed care services	1,263			1,353			2,645			2,719
Dental/Vision products and services	284			327			599			650
Other	110			91			206			176
Total Commercial & Specialty Business	8,789			9,417			18,150			18,809
Government Business
Managed care products	17,149			15,444			34,524			30,264
Managed care services	93			94			184			200
Total Government Business	17,242			15,538			34,708			30,464
IngenioRx
Pharmacy products and services	5,269			248			10,466			248
Total IngenioRx	5,269			248			10,466			248
Other
Other	1,452			546			2,479			1,094
Eliminations
Eliminations	(3,574		)	(572		)	(7,177		)	(1,050		)
Total product revenues	$	29,178		$	25,177		$	58,626		$	49,565

Reconciliation Of Reportable Segments Operating Revenues To Total Revenues Reported In The Consolidated Statements Of Income

A reconciliation of reportable segments’ operating revenue to the amounts of total revenues included in our consolidated statements of income for the three and six months ended June 30, 2020 and 2019 is as follows:

	Three Months Ended   June 30					Six Months Ended   June 30
	2020		2019			2020			2019
Reportable segments’ operating revenue	$	29,178	$	25,177		$	58,626		$	49,565
Net investment income	57		285			311			495
Net realized gains (losses) on financial instruments	18		11			(6		)	89
Impairment recoveries (losses) recognized in income	11		(7		)	(46		)	(17		)
Total revenues	$	29,264	$	25,466		$	58,885		$	50,132

Reconciliation Of Reportable Segments Operating Gain To Income Before Income Tax Expense Included In The Consolidated Statements Of Income

A reconciliation of reportable segments’ operating gain to income before income tax expense included in our consolidated statements of income for the three and six months ended June 30, 2020 and 2019 is as follows:

	Three Months Ended   June 30						Six Months Ended   June 30
	2020			2019			2020			2019
Reportable segments’ operating gain	$	3,360		$	1,433		$	5,554		$	3,373
Net investment income	57			285			311			495
Net realized gains (losses) on financial instruments	18			11			(6		)	89
Impairment recoveries (losses) recognized in income	11			(7		)	(46		)	(17		)
Interest expense	(201		)	(184		)	(395		)	(371		)
Amortization of other intangible assets	(93		)	(85		)	(176		)	(172		)
(Loss) gain on extinguishment of debt	(3		)	—			(4		)	1
Income before income tax expense	$	3,149		$	1,453		$	5,238		$	3,398